30 years of historical data (1996–2025) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
DaVita Inc. trades at 21.9x earnings, 66% above its 5-year average of 13.2x, sitting at the 79th percentile of its historical range. This is roughly in line with the Healthcare sector median P/E of 22.1x. On a free-cash-flow basis, the stock trades at 10.2x P/FCF, 27% above the 5-year average of 8.0x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $13.3B | $10.0B | $13.1B | $9.8B | $7.2B | $12.5B | $14.4B | $11.5B | $8.9B | $13.8B | $13.2B |
| Enterprise Value | $27.6B | $24.3B | $24.3B | $20.5B | $18.7B | $24.0B | $25.3B | $21.6B | $18.6B | $22.7B | $21.4B |
| P/E Ratio → | 21.86 | 11.95 | 13.94 | 14.12 | 13.08 | 12.78 | 18.37 | 14.24 | 11.24 | 20.82 | 14.97 |
| P/S Ratio | 0.98 | 0.73 | 1.02 | 0.80 | 0.62 | 1.08 | 1.25 | 1.01 | 0.78 | 1.27 | 0.89 |
| P/B Ratio | 15.81 | 8.64 | 6.24 | 3.56 | 3.22 | 5.28 | 4.97 | 3.30 | 1.76 | 2.34 | 2.26 |
| P/FCF | 10.18 | 7.64 | 8.90 | 6.55 | 7.45 | 9.70 | 11.04 | 8.84 | 11.31 | 13.79 | 11.60 |
| P/OCF | 7.08 | 5.31 | 6.45 | 4.74 | 4.57 | 6.48 | 7.27 | 5.57 | 5.01 | 7.25 | 6.70 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
DaVita Inc.'s enterprise value stands at 10.1x EBITDA, 13% above its 5-year average of 9.0x. The Healthcare sector median is 14.2x, placing the stock at a 29% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.78 | 1.90 | 1.69 | 1.61 | 2.07 | 2.19 | 1.90 | 1.64 | 2.08 | 1.45 |
| EV / EBITDA | 10.14 | 8.91 | 8.64 | 8.73 | 9.04 | 9.69 | 10.87 | 9.57 | 8.81 | 9.55 | 8.41 |
| EV / EBIT | 13.75 | 12.61 | 12.16 | 13.01 | 14.16 | 13.32 | 15.57 | 13.19 | 12.14 | 12.38 | 10.48 |
| EV / FCF | — | 18.54 | 16.59 | 13.75 | 19.49 | 18.63 | 19.37 | 16.55 | 23.77 | 22.60 | 18.82 |
Margins and return-on-capital ratios measuring operating efficiency
DaVita Inc. earns an operating margin of 14.7%. Operating margins have expanded from 13.2% to 14.7% over the past 3 years, signaling improving operational efficiency. Return on equity of 46.0% is exceptionally high. ROIC of 10.5% represents solid returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.0% | 27.0% | 32.9% | 31.5% | 29.3% | 31.4% | 30.8% | 30.5% | 28.1% | 29.8% | 22.2% |
| Operating Margin | 14.7% | 14.7% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | 16.7% | 13.8% |
| Net Profit Margin | 5.5% | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | 6.1% | 6.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 46.0% | 46.0% | 38.7% | 27.8% | 24.4% | 37.1% | 24.2% | 19.0% | 2.9% | 11.3% | 14.9% |
| ROA | 4.3% | 4.3% | 5.5% | 4.1% | 3.3% | 5.7% | 4.5% | 4.5% | 0.8% | 3.5% | 4.7% |
| ROIC | 10.5% | 10.5% | 11.7% | 8.8% | 7.3% | 9.8% | 9.3% | 8.7% | 7.7% | 9.4% | 10.9% |
| ROCE | 14.0% | 14.0% | 14.6% | 11.2% | 9.2% | 12.3% | 11.5% | 11.3% | 10.1% | 11.3% | 12.6% |
Solvency and debt-coverage ratios — lower is generally safer
DaVita Inc. carries a Debt/EBITDA ratio of 5.5x, which is highly leveraged (72% above the sector average of 3.2x). Net debt stands at $14.3B ($15.0B total debt minus $758M cash). Interest coverage of 3.5x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 12.99 | 12.99 | 5.77 | 4.05 | 5.31 | 5.05 | 3.86 | 3.19 | 2.01 | 1.58 | 1.56 |
| Debt / EBITDA | 5.52 | 5.52 | 4.29 | 4.73 | 5.71 | 4.83 | 4.81 | 4.95 | 4.77 | 3.93 | 3.59 |
| Net Debt / Equity | — | 12.34 | 5.39 | 3.91 | 5.20 | 4.86 | 3.75 | 2.88 | 1.94 | 1.50 | 1.41 |
| Net Debt / EBITDA | 5.24 | 5.24 | 4.01 | 4.57 | 5.59 | 4.65 | 4.67 | 4.46 | 4.62 | 3.72 | 3.23 |
| Debt / FCF | — | 10.90 | 7.69 | 7.20 | 12.05 | 8.93 | 8.33 | 7.71 | 12.47 | 8.81 | 7.23 |
| Interest Coverage | 3.51 | 3.51 | 4.25 | 3.95 | 3.71 | 6.32 | 5.33 | 3.69 | 3.15 | 4.25 | 4.92 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.29x means DaVita Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 1.19x to 1.29x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.29 | 1.29 | 1.26 | 1.19 | 1.20 | 1.32 | 1.27 | 1.56 | 1.72 | 2.88 | 1.48 |
| Quick Ratio | 1.24 | 1.24 | 1.21 | 1.13 | 1.16 | 1.28 | 1.23 | 1.51 | 1.70 | 2.82 | 1.41 |
| Cash Ratio | 0.25 | 0.25 | 0.28 | 0.15 | 0.12 | 0.20 | 0.14 | 0.47 | 0.07 | 0.18 | 0.37 |
| Asset Turnover | — | 0.78 | 0.74 | 0.72 | 0.69 | 0.68 | 0.68 | 0.66 | 0.60 | 0.57 | 0.79 |
| Inventory Turnover | 62.00 | 62.00 | 63.90 | 58.14 | 75.23 | 74.21 | 71.57 | 80.80 | 76.32 | 42.02 | 45.08 |
| Days Sales Outstanding | — | 79.16 | 72.85 | 72.64 | 80.19 | 75.73 | 77.07 | 73.88 | 76.71 | 72.60 | 44.36 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
DaVita Inc. returns 13.4% to shareholders annually primarily through share buybacks. The earnings yield of 4.6% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.6% | 8.4% | 7.2% | 7.1% | 7.6% | 7.8% | 5.4% | 7.0% | 8.9% | 4.8% | 6.7% |
| FCF Yield | 9.8% | 13.1% | 11.2% | 15.3% | 13.4% | 10.3% | 9.1% | 11.3% | 8.8% | 7.2% | 8.6% |
| Buyback Yield | 13.4% | 17.9% | 10.6% | 2.8% | 11.2% | 12.8% | 10.1% | 20.7% | 13.1% | 5.8% | 8.3% |
| Total Shareholder Yield | 13.4% | 17.9% | 10.6% | 2.8% | 11.2% | 12.8% | 10.1% | 20.7% | 13.1% | 5.8% | 8.3% |
| Shares Outstanding | — | $88M | $87M | $93M | $96M | $110M | $123M | $154M | $172M | $191M | $205M |
Compare DVA with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $13B | 21.9 | 10.1 | 10.2 | 27.0% | 14.7% | 46.0% | 10.5% | 5.5 | |
| $13B | 12.3 | 6.3 | 6.7 | 25.6% | 9.3% | 6.5% | 5.6% | 3.3 | |
| $265M | 15.0 | 6.7 | 12.6 | 74.0% | 19.6% | 10.0% | 7.7% | 1.9 | |
| $364B | 30.3 | 17.9 | 22.6 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 | |
| $43B | 36.7 | 22.9 | 115.5 | 14.5% | 1.1% | 7.0% | 4.1% | 5.7 | |
| $30B | -4.5 | — | 7.0 | 12.2% | -3.9% | -28.7% | -21.6% | — | |
| $964M | 44.6 | 13.2 | 15.8 | 20.1% | 10.3% | 2.0% | 5.6% | 4.1 | |
| $589M | 12.7 | 8.8 | 66.0 | 46.4% | 18.6% | 18.5% | 21.9% | 0.0 | |
| $1B | 39.8 | 26.7 | 44.2 | 12.9% | 5.4% | 8.6% | 5.6% | 7.6 | |
| $2B | 18.1 | 12.2 | 16.9 | 32.5% | 9.7% | 9.3% | 8.8% | 1.3 | |
| $10B | -11.4 | 27.2 | 31.8 | 30.1% | -2.7% | -14.6% | -1.4% | 14.9 | |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
Deep dive into DVA consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying DVA stock.
DaVita Inc.'s current P/E ratio is 21.9x. The historical average is 24.7x. This places it at the 79th percentile of its historical range.
DaVita Inc.'s current EV/EBITDA is 10.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.9x.
DaVita Inc.'s return on equity (ROE) is 46.0%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 22.1%.
Based on historical data, DaVita Inc. is trading at a P/E of 21.9x. This is at the 79th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
DaVita Inc. has 27.0% gross margin and 14.7% operating margin. Operating margin between 10-20% is typical for established companies.
DaVita Inc.'s Debt/EBITDA ratio is 5.5x, indicating high leverage. A ratio above 4x may signal elevated financial risk.